Amgen, Inc. (AMGN)
438.94
+14.00
(+3.29%)
USD |
NASDAQ |
Oct 20, 16:00
434.22
-4.72
(-1.08%)
After-Hours: 06:51
Amgen Gross Profit (TTM) : 27.78B for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.78B |
| March 31, 2026 | 26.68B |
| December 31, 2025 | 25.89B |
| September 30, 2025 | 25.29B |
| June 30, 2025 | 23.94B |
| March 31, 2025 | 22.88B |
| December 31, 2024 | 21.95B |
| September 30, 2024 | 19.47B |
| June 30, 2024 | 19.38B |
| March 31, 2024 | 19.42B |
| December 31, 2023 | 19.56B |
| September 30, 2023 | 19.54B |
| June 30, 2023 | 19.48B |
| March 31, 2023 | 19.37B |
| December 31, 2022 | 19.69B |
| September 30, 2022 | 19.79B |
| June 30, 2022 | 19.90B |
| March 31, 2022 | 19.77B |
| December 31, 2021 | 19.53B |
| September 30, 2021 | 19.44B |
| June 30, 2021 | 19.16B |
| March 31, 2021 | 18.90B |
| December 31, 2020 | 19.09B |
| September 30, 2020 | 18.98B |
| June 30, 2020 | 18.83B |
| Date | Value |
|---|---|
| March 31, 2020 | 19.02B |
| December 31, 2019 | 18.90B |
| September 30, 2019 | 19.10B |
| June 30, 2019 | 19.29B |
| March 31, 2019 | 19.51B |
| December 31, 2018 | 19.67B |
| September 30, 2018 | 19.33B |
| June 30, 2018 | 19.25B |
| March 31, 2018 | 18.95B |
| December 31, 2017 | 18.72B |
| September 30, 2017 | 18.78B |
| June 30, 2017 | 18.71B |
| March 31, 2017 | 18.52B |
| December 31, 2016 | 18.52B |
| September 30, 2016 | 18.08B |
| June 30, 2016 | 17.98B |
| March 31, 2016 | 17.63B |
| December 31, 2015 | 17.26B |
| September 30, 2015 | 17.07B |
| June 30, 2015 | 16.44B |
| March 31, 2015 | 16.33B |
| December 31, 2014 | 15.82B |
| September 30, 2014 | 15.60B |
| June 30, 2014 | 15.57B |
| March 31, 2014 | 15.36B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Gilead Sciences, Inc. | 24.33B |
| Regeneron Pharmaceuticals, Inc. | 12.65B |
| AbbVie, Inc. | 45.98B |
| Biogen, Inc. | 6.211B |
| Abbott Laboratories | 24.60B |